Imuran and Multihance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imuran (azathioprine) and Multihance (gadobenate dimeglumine). Common drug interactions include nephrogenic systemic fibrosis among females and general physical health deterioration among males.

The phase IV clinical study analyzes what interactions people have when they take Imuran and Multihance. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Imuran?

Imuran has active ingredients of azathioprine. It is often used in crohn's disease. eHealthMe is studying from 34,915 Imuran users. Check the latest studies of Imuran.

What is Multihance?

Multihance has active ingredients of gadobenate dimeglumine. eHealthMe is studying from 5,786 Multihance users. Check the latest studies of Multihance.

On Jul, 27, 2026

20 people who take Imuran and Multihance together, and have interactions are studied.

Imuran and Multihance drug interactions.

What are the common drug interactions of Imuran and Multihance, by gender? *:

female:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Asthenia (weakness)
Mobility decreased (ability to move is reduced)
Pain
Contrast media reaction (reaction associated with the use of intravenous contrast material during radiology)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Emotional distress
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Gait disturbance

male:

General physical health deterioration (weak health status)
Joint range of motion decreased (disease of joint movement)
Joint stiffness
Mobility decreased (ability to move is reduced)
Muscle contractions involuntary (uncontrolled muscle contraction)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Oedema peripheral (superficial swelling)
Skin discolouration (change of skin colour)
Skin fibrosis (fibrous tissue formation on skin)
Skin hyperpigmentation (disorders affect the colour of your skin)

What are the common drug interactions of Imuran and Multihance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Asthenia (weakness)
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Gait disturbance
Hypoaesthesia (reduced sense of touch or sensation)
Joint range of motion decreased (disease of joint movement)
Joint stiffness
Mobility decreased (ability to move is reduced)
Muscle tightness
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

30-39:

n/a

40-49:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Dry skin
Emotional distress
General physical health deterioration (weak health status)
Joint contracture (a permanent shortening of a muscle or joint)
Joint range of motion decreased (disease of joint movement)
Neuropathic arthropathy (a progressive destruction of bone and joints)
Oedema (fluid collection in tissue)

50-59:

Arthralgia (joint pain)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Gait disturbance
General physical health deterioration (weak health status)
Joint range of motion decreased (disease of joint movement)
Joint stiffness
Mobility decreased (ability to move is reduced)
Muscle contractions involuntary (uncontrolled muscle contraction)
Muscular weakness (muscle weakness)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

60+:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Pain
Pain of skin
Peau d'orange (orange peel skin)
Pruritus (severe itching of the skin)
Scar
Skin hypertrophy (skin cells enlarges)
Skin lesion
Skin tightness

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Abdominal: 8 people, 40.00%
Nuclear Magnetic Resonance Imaging Brain: 4 people, 20.00%
Renal Vein Thrombosis (blood clot in renal vein): 1 person, 5.00%
Ovarian Mass (mass in ovary): 1 person, 5.00%
Hepatic Vein Obstruction (Budd-Chiari) (blockage of the hepatic vein): 1 person, 5.00%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 5.00%
Abdominal Pain: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Imuran and Multihance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously